-
Mashup Score: 25
Oral vonoprazan is noninferior to intravenous proton pump inhibitors in preventing 30-day rebleeding in high-risk peptic ulcers after successful hemostasis with a comparable safety profile.
Source: www.gastrojournal.orgCategories: General Medicine News, GastroenterologyTweet
-
Mashup Score: 0Patients with SSc-related digital ulcers use ‘significantly more’ health care resources - 3 year(s) ago
Patients with systemic sclerosis who demonstrate digital ulcers use “significantly more” health care resources annually than patients without digital ulcers, according to data published in Arthritis Care and Research. “[Digital ulcers (DUs)] are slow to heal, specially if there is calcinosis, and can be complicated by soft tissue infections, wet and dry necrosis, eschar,
Source: www.healio.comCategories: General Medicine News, Latest HeadlinesTweet-
From @HealioRheum: Patients with #systemicsclerosis who demonstrate digital ulcers use “significantly more” health care resources annually than patients without digital #ulcers #RheumTwitter https://t.co/6cxqTlUnDx
-
-
Mashup Score: 0Proton Pump Inhibitor Use Linked to Higher Mortality Rate in Critically Ill Patients - 4 year(s) ago
Both proton pump inhibitors and histamine 2 receptor antagonists are commonly prescribed for stress ulcer prophylaxis in critically ill patients.
Source: HCPLive®Categories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 0Increased Mortality in Patients With Chronic Ulcers - 4 year(s) ago
Written by Eliot N. Mostow MD, MPH
Source: PracticeUpdateCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 0Systematic Review and Meta-Analysis of Prophylactic Transarterial Embolization for High-Risk Bleeding Peptic Ulcer Disease - 4 year(s) ago
The present systematic review determined the role of transarterial embolization (TAE) as a prophylactic treatment in bleeding peptic ulcers after initial successful endoscopic hemostasis. PubMed and Ovid Medline databases were searched from inception until July 2019 for studies that included patients deemed high-risk based on Forrest Classification, Rockall score ≥ 5, or endoscopic evaluation in…
Categories: Latest Headlines, RadiologyTweet
-
Mashup Score: 0Common OTC drugs and medical conditions that don’t mix | MDLinx - 4 year(s) ago
The elderly and patients with certain medical conditions should avoid using these over-the-counter drugs.
Source: MDLinxCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 0Digital ulcers, Raynaud's, GI issues biggest detriments to QoL in systemic sclerosis - 5 year(s) ago
Digital ulcers, Raynaud symptoms and gastrointestinal complications are the biggest contributors to worsening quality of life in patients with systemic sclerosis, according to data published in Rheumatology. “Previous studies have evaluated SSc-related HRQoL cross-sectionally,” Nina M. van Leeuwen, MD, who at the time of the study was a researcher at Leiden University Medical Center,
Source: www.healio.comCategories: Latest Headlines, RheumatologyTweet
-
Mashup Score: 0Unlocking the Potential of Immuno-Oncology in Advanced Cutaneous Squamous Cell Carcinoma: Role of Checkpoint Blockade - European Medical Journal - 5 year(s) ago
The rising incidence of CSCC presents a major challenge for healthcare systems and the frequency and impact of progression to advanced disease is…
Source: European Medical JournalCategories: Dermatology, Latest HeadlinesTweet
-
Mashup Score: 9Stomach Ulcer Diet: Foods to Eat and Avoid - 5 year(s) ago
If you have a peptic ulcer, try eating – and avoiding – certain foods for better symptom control.
Source: US News & World ReportCategories: Gastroenterology, Latest HeadlinesTweet
-
Mashup Score: 5Raynaud phenomenon and digital ulcers in systemic sclerosis - 5 year(s) ago
Raynaud phenomenon and digital ulcers are some of the most common and difficult to treat manifestations of systemic sclerosis. In this Review, the authors outline how to assess and treat these conditions, and also discuss unmet clinical needs.
Source: Nature Reviews RheumatologyCategories: Latest Headlines, RheumatologyTweet
Multicenter randomized noninferiority trial compares vonoprazan and intravenous proton pump inhibitor for prevention of high-risk peptic #ulcers rebleeding after successful endoscopic hemostasis. Learn more at https://t.co/u7lToqcNiv https://t.co/r1YvnSQcmo